JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH
The Global Network on Access to Medicines (GNAM)
is a working group based within the Johns Hopkins Center for Drug Safety
and Effectiveness (CDSE) and the Department of International Health. Our
primary objective is to increase awareness around issues concerning quality
and equitable access to medicines. To achieve this goal, we are creating a
network for students and professionals throughout Maryland, Virginia and
Washington DC to increase exposure to innovation and research in this
space. These include: medicines selection and use, sustainable financing
and affordability, leadership and governance, availability of medicines,
human resources for health, drug resistance, quality assurance systems,
and information systems.
Global Access to
Medicines Conference
For additional information email Gaurvika Nayyar at
[email protected]
This event is sponsored by the Center for Drug Safety and Effectiveness (CDSE),
Department of International Health
Safeguarding Quality in the
Global Medicines Supply Chain
April 18, 2014 • 3:00 – 7:30 p.m.
Johns Hopkins Bloomberg School of Public Health
Sheldon Hall
Speakers
Joel G. Breman, MD, DTPH | Senior Scientific Advisor Emeritus, National Institutes of Health | Dr.
Breman brings four decades of experience leading global programs. He has served as the
CDC/USAID Chief of Party for the West and Central African Smallpox Eradication-Measles Control
Program, as well as Chief of the Epidemiology Section at the Organization for Coordination and
Cooperation in the Control of the Major Endemic Diseases. His research work on poor quality
antimalarials has been published in the Lancet and his advocacy and leadership activities in this field
have been covered by NYT, WSJ, BBC and others.
Patrick Lukulay, MS, PhD | VP of Global Health Impact Programs at U.S. Pharmacopeial
Convention | Dr. Lukulay’s interests include partnering with developing countries and other
stakeholders to improve drug quality. He has held a number of leadership positions at Wyeth
Pharmaceuticals and Pfizer as lead scientist. He has authored more than fifteen publications, and is
a frequent speaker at national and international conferences on quality control and assurance
systems for medicines.
David Lee, MD | Global Technical Lead, Pharmaceutical Management and Director, Technical
Strategy and Quality for the MSH Center for Pharmaceutical Management | Dr. Lee has 30 years of
experience in pharmaceutical management, evaluation, and providing technical assistance in Africa,
Asia and the Americas. At MSH, Lee is responsible for technical strategy oversight of MSH/CPM
projects, and designing and managing pharmaceutical sector studies.
Libby Baney, JD | Executive Director, Alliance for Safe Online Pharmacies | CEO, FWD Strategies
International, a globally active nonprofit organization. As the founding Executive Director of the
Alliance for Safe Online Pharmacies, Mrs. Baney shapes public policy, and advocates for increased
international attention to issue of illegal online drug sellers. In addition to her work with ASOP,
Libby also runs a consulting firm, FWD Strategies International, through which she advises a variety
of industries including pharmaceutical, pharmacy, and technology.
Peter Maybardurk, JD | Director of Public Citizen's Global Access to Medicines Program | Mr.
Maybardurk helps developing countries overcome patent-based and other pharmaceutical
monopolies in order to promote access to medicines for all. He works with partners in every
continent and his work has yielded major HIV/AIDS medicine price reductions, new state access to
medicines policies, and global shifts toward anti-counterfeiting policies that safeguard generic
competition.
Faculty Advisors
Caleb Alexander, MD | Co-Director, Center for Drug Safety and Effectiveness | Associate
Professor, Johns Hopkins School of Public Health | He is a practicing general internist, health
services researcher, and pharmacoepidemiologist. His research examines three interrelated areas of
medication use: patient-physician communication and decision-making regarding prescription drugs,
population-based patterns and determinants of pharmaceutical use, and the impact of changes in
pharmaceutical policy on pharmaceutical expenditures and utilization..
David Peters, MD | Chair, Department of International Health | Professor, Johns Hopkins School of
Public Health | He has worked in health systems as a leader in developing countries over the last
two decades. His work addresses the performance of health systems, poverty and health systems,
implementation of health services in low-income countries, innovations in organization, technology,
and financing of health systems, the role of the private sector, and institutional capacity in lowincome countries.
Global Access to Medicines Conference
April 18, 2014 • Sheldon Hall
Johns Hopkins Bloomberg School of Public Health
Time (p.m.)
3:00 - 3:15
Presentations
Opening Remarks
Caleb Alexander, Director of the Center for Drug Safety and Effectiveness
Gaurvika Nayyar, President of Global Network for Access to Medicines
Session I
3:15 - 3:30
3:30 - 3:55
3:55 - 4:20
4:20 - 4:45
4:45 - 5:00
A Snapshot of the Problem
Joel G. Breman, National Institutes of Health
Keynote Address: Global Challenges and Solutions in securing the medicines supply chain
Patrick Lukulay, United States Pharmacopeia
Technical Implementation Perspectives: Protecting Quality of Medicines in Developing Countries
David Lee, Management Sciences for Health
Questions
Break
Session II
5:00 - 5:25
5:25 - 5:50
5:50 - 6:05
Regulatory & Policy Perspectives: Global Drug Safety and Access
Peter Maybarduk, Public Citizen
Working Together on Global Solutions to Combat Illegal Online Drug Sellers
Libby Baney, Alliance for Safe Online Pharmacies
Questions
Wrap Up
6:05 - 6:20
6:20 - 6:30
6:30 - 7:30
Closing Remarks
David Peters, Chair of the International Health Department
Thank You Note
Gaurvika Nayyar, President of Global Network for Access to Medicines
Reception & Networking Activity